Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART

被引：0
|
作者：
Potena, L. [1 ]
Barberini, F. [1 ]
Boffini, M. [2 ]
Amarelli, C. [3 ]
Pellegrini, C. [4 ]
Livi, U. [5 ]
Masciocco, G. [6 ]
Faggian, G. [7 ]
Gerosa, G. [8 ]
Lilla, P. [9 ]
Marraudino, N. [10 ]
Porcu, M. [11 ]
Guarisco, R. [12 ]
Maccherini, M. [13 ]
机构：
[1] AO S Orsola Malpighi, Bologna, Italy
[2] ASO Molinette S Giovanni Battista, Turin, Italy
[3] Osped Monaldi, Naples, Italy
[4] Policlin San Matteo, I-27100 Pavia, Italy
[5] AOU S Maria Misericordia, Udine, Italy
[6] AO Niguarda Ca Granda, Milan, Italy
[7] Osped Civile, I-37126 Verona, Italy
[8] AOU Padova, Padua, Italy
[9] AO San Camillo Forlanini, Rome, Italy
[10] Policlin Bari, Bari, Italy
[11] AO G Brotzu, Cagliari, Italy
[12] Novartis Farma, Origgio, VA, Italy
[13] AOU Senese, Siena, Italy
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2013年 / 32卷 / 04期
关键词：
D O I：
10.1016/j.healun.2013.01.303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
352
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [21] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [22] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [23] Early Conversion to Everolimus in De Novo Renal Transplant Recipients: Incidence of Viral Infections in the Randomized-Controlled ELEVATE Study.
    Hirsch, H.
    De Fijter, J.
    van der Giet, M.
    Zeier, M.
    Pascual, J.
    Avihingsanon, Y.
    Lopez, P.
    Aguilar-Sanchez, J.
    Kochuparampil, J.
    Wang, Z.
    Holdaas, H.
    Cruzado, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 293 - 294
  • [24] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [25] Cardiovascular Events with De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study
    Potena, L.
    Schultz, U.
    Bara, C.
    Arizon, J. M.
    Dong, G.
    Lopez, P.
    Epailly, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S26 - S26
  • [26] Everolimus in de novo liver transplant recipients: a systematic review
    Cheng-Yong Tang
    Ai Shen
    Xu-Fu Wei
    Qing-Dong Li
    Rui Liu
    He-Jun Deng
    Yong-Zhong Wu
    Zhong-Jun Wu
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (05) : 461 - 469
  • [27] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530
  • [28] Everolimus in de novo liver transplant recipients: a systematic review
    Tang, Cheng-Yong
    Shen, Ai
    Wei, Xu-Fu
    Li, Qing-Dong
    Liu, Rui
    Deng, He-Jun
    Wu, Yong-Zhong
    Wu, Zhong-Jun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (05) : 461 - 469
  • [29] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Jiang, Hai
    Junge, Guido
    HEPATOLOGY, 2011, 54 : 1430A - 1431A
  • [30] Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients
    Lehmkuhl, Hans B.
    Mai, Daniel
    Dandel, Michael
    Knosalla, Christoph
    Hiemann, Nicola E.
    Grauhan, Onnen
    Huebler, Michael
    Pasic, Miralem
    Weng, Yuguo
    Meyer, Rudolph
    Rothenburger, Markus
    Hummel, Manfred
    Hetzer, Roland
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (07): : 700 - 704
12345